Comment
doi: 10.5694/mja12.11439.
The pricing of statins and implications for Pharmaceutical Benefits Scheme expenditure
- PMID: 23496399
- DOI: 10.5694/mja12.11439
Item in Clipboard
Comment
The pricing of statins and implications for Pharmaceutical Benefits Scheme expenditure
Med J Aust.
.
No abstract available
Comment on
-
Expiry of patent protection on statins: effects on pharmaceutical expenditure in Australia.Med J Aust. 2010 Jun 7;192(11):633-6. doi: 10.5694/j.1326-5377.2010.tb03661.x. Med J Aust. 2010. PMID: 20528715
-
Challenges and opportunities for the Pharmaceutical Benefits Scheme.Med J Aust. 2012 Feb 20;196(3):153-4. doi: 10.5694/mja12.10092. Med J Aust. 2012. PMID: 22339510 No abstract available.